相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Verinurad combined with febuxostat in Japanese adults with gout or asymptomatic hyperuricaemia: a phase 2a, open-label study
Masanari Shiramoto et al.
RHEUMATOLOGY (2018)
Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy Japanese and non-Asian male subjects
Jesse Hall et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label study
Roy Fleischmann et al.
RMD OPEN (2018)
Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with febuxostat in adults with gout: a phase IIa, open-label study
Roy Fleischmann et al.
RMD OPEN (2018)
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)
Thomas Bardin et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
2016 updated EULAR evidence-based recommendations for the management of gout
P. Richette et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Serum uric acid levels and the risk of flares among gout patients in a US managed care setting
Aki Shiozawa et al.
CURRENT MEDICAL RESEARCH AND OPINION (2017)
Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study)
Kenneth G. Saag et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study
Anne-Kathrin Tausche et al.
RHEUMATOLOGY (2017)
Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy adult male subjects
Zancong Shen et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout Findings of a Phase III Clinical Trial
Nicola Dalbeth et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout
Philip K. Tan et al.
SCIENTIFIC REPORTS (2017)
Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol
Fernando Perez-Ruiz et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Clinical Phenotype Classifications Based on Static Varus Alignment and Varus Thrust in Japanese Patients With Medial Knee Osteoarthritis
Hirotaka Iijima et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Optimizing current treatment of gout
Frances Rees et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Gout treatment: should we aim for rapid crystal dissolution?
Eliseo Pascual et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
Dinesh Khanna et al.
ARTHRITIS CARE & RESEARCH (2012)
The effect of gout on health-related quality of life, work productivity, resource use and clinical outcomes among patients with hypertension
Marco daCosta DiBonaventura et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2012)
Difficult-to-Treat Gouty Arthritis A Disease Warranting Better Management
Naomi Schlesinger
DRUGS (2011)
JAPANESE GUIDELINE FOR THE MANAGEMENT OF HYPERURICEMIA AND GOUT: SECOND EDITION
Hisashi Yamanaka
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2011)
Risk Factors Associated With Renal Lithiasis During Uricosuric Treatment of Hyperuricemia in Patients With Gout
Fernando Perez-Ruiz et al.
ARTHRITIS CARE & RESEARCH (2010)
Treating to target: a strategy to cure gout
Fernando Perez-Ruiz
RHEUMATOLOGY (2009)
A benefit-risk assessment of benzbromarone in the treatment of gout - Was its withdrawal from the market in the best interest of patients?
Ming-Han H. Lee et al.
DRUG SAFETY (2008)
Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout
J. Vazquez-Mellado et al.
RHEUMATOLOGY (2007)
EULAR evidence based recommendations for gout.: Part II:: Management.: Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT)
W. Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout
F Perez-Ruiz et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2002)
分享论文
